FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2285367051> ?p ?o ?g. }

• W2285367051 endingPage "431" @default.
• W2285367051 startingPage "421" @default.
• W2285367051 abstract "The mainstay of asthma therapy, glucocorticoids (GCs) exert their therapeutic effects through the inhibition of inflammatory signaling and induction of eosinophil apoptosis. However, laboratory and clinical observations of GC-resistant asthma suggest that GCs' effects on eosinophil viability may depend on the state of eosinophil activation. In the present study we demonstrate that eosinophils stimulated with IL-5 show impaired pro-apoptotic response to GCs. We sought to determine the contribution of GC-mediated transactivating (TA) and transrepressing (TR) pathways in modulation of activated eosinophils' response to GC by comparing their response to the selective GC receptor (GR) agonist Compound A (CpdA) devoid of TA activity to that upon treatment with Dexamethasone (Dex). IL-5-activated eosinophils showed contrasting responses to CpdA and Dex, as IL-5-treated eosinophils showed no increase in apoptosis compared to cells treated with Dex alone, while CpdA elicited an apoptotic response regardless of IL-5 stimulation. Proteomic analysis revealed that both Nuclear Factor IL-3 (NFIL3) and Map Kinase Phosphatase 1 (MKP1) were inducible by IL-5 and enhanced by Dex; however, CpdA had no effect on NFIL3 and MKP1 expression. We found that inhibiting NFIL3 with specific siRNA or by blocking the IL-5-inducible Pim-1 kinase abrogated the protective effect of IL-5 on Dex-induced apoptosis, indicating crosstalk between IL-5 anti-apoptotic pathways and GR-mediated TA signaling occurring via the NFIL3 molecule. Collectively, these results indicate that (1) GCs' TA pathway may support eosinophil viability in IL-5-stimulated cells through synergistic upregulation of NFIL3; and (2) functional inhibition of IL-5 signaling (anti-Pim1) or the use of selective GR agonists that don't upregulate NFIL3 may be effective strategies for the restoring pro-apoptotic effect of GCs on IL-5-activated eosinophils." @default.
• W2285367051 created "2016-06-24" @default.
• W2285367051 creator A5002841136 @default.
• W2285367051 creator A5007994290 @default.
• W2285367051 creator A5013534230 @default.
• W2285367051 creator A5049498047 @default.
• W2285367051 creator A5081271871 @default.
• W2285367051 date "2016-02-15" @default.
• W2285367051 modified "2023-09-29" @default.
• W2285367051 title "Eosinophil resistance to glucocorticoid-induced apoptosis is mediated by the transcription factor NFIL3" @default.
• W2285367051 cites W1480416172 @default.
• W2285367051 cites W1484315431 @default.
• W2285367051 cites W1496802676 @default.
• W2285367051 cites W1919677047 @default.
• W2285367051 cites W1923918998 @default.
• W2285367051 cites W1930073633 @default.
• W2285367051 cites W1940608889 @default.
• W2285367051 cites W1969109740 @default.
• W2285367051 cites W1977176665 @default.
• W2285367051 cites W1977436614 @default.
• W2285367051 cites W1988758075 @default.
• W2285367051 cites W1990586585 @default.
• W2285367051 cites W1996021680 @default.
• W2285367051 cites W1996770096 @default.
• W2285367051 cites W1998805154 @default.
• W2285367051 cites W2003387372 @default.
• W2285367051 cites W2006950815 @default.
• W2285367051 cites W2008390304 @default.
• W2285367051 cites W2011417333 @default.
• W2285367051 cites W2031794136 @default.
• W2285367051 cites W2033341978 @default.
• W2285367051 cites W2044021880 @default.
• W2285367051 cites W2050477128 @default.
• W2285367051 cites W2054115898 @default.
• W2285367051 cites W2062918919 @default.
• W2285367051 cites W2087387925 @default.
• W2285367051 cites W2088105818 @default.
• W2285367051 cites W2088431330 @default.
• W2285367051 cites W2090687056 @default.
• W2285367051 cites W2091401210 @default.
• W2285367051 cites W2096009880 @default.
• W2285367051 cites W2103830615 @default.
• W2285367051 cites W2108212140 @default.
• W2285367051 cites W2113025135 @default.
• W2285367051 cites W2123944872 @default.
• W2285367051 cites W2126995562 @default.
• W2285367051 cites W2133387174 @default.
• W2285367051 cites W2135268524 @default.
• W2285367051 cites W2139210823 @default.
• W2285367051 cites W2142101937 @default.
• W2285367051 cites W2145842404 @default.
• W2285367051 cites W2147277158 @default.
• W2285367051 cites W2150341448 @default.
• W2285367051 cites W2155720651 @default.
• W2285367051 cites W2164141963 @default.
• W2285367051 cites W2168691139 @default.
• W2285367051 cites W2168789122 @default.
• W2285367051 cites W2344597411 @default.
• W2285367051 doi "https://doi.org/10.1007/s10495-016-1226-5" @default.
• W2285367051 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4769953" @default.
• W2285367051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26880402" @default.
• W2285367051 hasPublicationYear "2016" @default.
• W2285367051 type Work @default.
• W2285367051 sameAs 2285367051 @default.
• W2285367051 citedByCount "33" @default.
• W2285367051 countsByYear W22853670512016 @default.
• W2285367051 countsByYear W22853670512017 @default.
• W2285367051 countsByYear W22853670512018 @default.
• W2285367051 countsByYear W22853670512019 @default.
• W2285367051 countsByYear W22853670512020 @default.
• W2285367051 countsByYear W22853670512021 @default.
• W2285367051 countsByYear W22853670512022 @default.
• W2285367051 countsByYear W22853670512023 @default.
• W2285367051 crossrefType "journal-article" @default.
• W2285367051 hasAuthorship W2285367051A5002841136 @default.
• W2285367051 hasAuthorship W2285367051A5007994290 @default.
• W2285367051 hasAuthorship W2285367051A5013534230 @default.
• W2285367051 hasAuthorship W2285367051A5049498047 @default.
• W2285367051 hasAuthorship W2285367051A5081271871 @default.
• W2285367051 hasBestOaLocation W22853670512 @default.
• W2285367051 hasConcept C181901479 @default.
• W2285367051 hasConcept C190283241 @default.
• W2285367051 hasConcept C203014093 @default.
• W2285367051 hasConcept C2776042228 @default.
• W2285367051 hasConcept C2777037409 @default.
• W2285367051 hasConcept C2778690821 @default.
• W2285367051 hasConcept C2780841215 @default.
• W2285367051 hasConcept C502942594 @default.
• W2285367051 hasConcept C55493867 @default.
• W2285367051 hasConcept C59493245 @default.
• W2285367051 hasConcept C62478195 @default.
• W2285367051 hasConcept C74172505 @default.
• W2285367051 hasConcept C86803240 @default.
• W2285367051 hasConcept C95444343 @default.
• W2285367051 hasConceptScore W2285367051C181901479 @default.
• W2285367051 hasConceptScore W2285367051C190283241 @default.
• W2285367051 hasConceptScore W2285367051C203014093 @default.
• W2285367051 hasConceptScore W2285367051C2776042228 @default.

• next